Good prognosis for primary ovarian pure nongestational choriocarcinoma using the EMA/CO regime

Nongestational choriocarcinoma of the ovary is a rare germ cell tumor with a worse prognosis than gestational choriocarcinoma. In this report we present a case of nongestational chroriocarcinoma where the EMA/CO regime was applied. The clinical features, management, and outcome are discussed.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of gynaecological oncology 2010, Vol.31 (1), p.123-125
Hauptverfasser:	Ozturk, E, Ugur, M Gurol, Cebesoy, F Bahar, Aydin, A, Sever, T, Balat, O
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - therapeutic use Choriocarcinoma, Non-gestational - drug therapy Choriocarcinoma, Non-gestational - pathology Choriocarcinoma, Non-gestational - surgery Cyclophosphamide - administration & dosage Dactinomycin - administration & dosage Etoposide - administration & dosage Female Humans Methotrexate - administration & dosage Ovarian Neoplasms - drug therapy Ovarian Neoplasms - pathology Ovarian Neoplasms - surgery Prognosis Vincristine - administration & dosage Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Nongestational choriocarcinoma of the ovary is a rare germ cell tumor with a worse prognosis than gestational choriocarcinoma. In this report we present a case of nongestational chroriocarcinoma where the EMA/CO regime was applied. The clinical features, management, and outcome are discussed.
ISSN:	0392-2936